Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Teleflex Incorporated (TFX) Stock Forecast & Price Prediction United States | NYSE | Healthcare | Medical Instruments & Supplies
$107.32
-0.94 (-0.87%)Did TFX Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Teleflex is one of their latest high-conviction picks.
Based on our analysis of 26 Wall Street analysts, TFX has a neutral consensus with a median price target of $135.00 (ranging from $115.00 to $155.00). The overall analyst rating is Buy (6.2/10). Currently trading at $107.32, the median forecast implies a 25.8% upside. This outlook is supported by 2 Buy, 9 Hold, and 1 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for TFX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 27, 2026 | RBC Capital | Shagun Singh | Sector Perform | Maintains | $125.00 |
| Feb 27, 2026 | Wells Fargo | Larry Biegelsen | Equal-Weight | Maintains | $130.00 |
| Feb 26, 2026 | Needham | Mike Matson | Buy | Maintains | $147.00 |
| Jan 29, 2026 | Wells Fargo | Larry Biegelsen | Equal-Weight | Maintains | $116.00 |
| Jan 27, 2026 | Needham | Mike Matson | Buy | Upgrade | $138.00 |
| Dec 18, 2025 | Truist Securities | Ravi Misra | Hold | Maintains | $135.00 |
| Dec 10, 2025 | Wells Fargo | Larry Biegelsen | Equal-Weight | Maintains | $139.00 |
| Nov 10, 2025 | Truist Securities | Ravi Misra | Hold | Maintains | $120.00 |
| Nov 7, 2025 | RBC Capital | Shagun Singh | Sector Perform | Maintains | $120.00 |
| Nov 7, 2025 | Wells Fargo | Larry Biegelsen | Equal-Weight | Maintains | $114.00 |
| Aug 1, 2025 | Wells Fargo | Larry Biegelsen | Equal-Weight | Maintains | $131.00 |
| Aug 1, 2025 | RBC Capital | Shagun Singh | Sector Perform | Maintains | $135.00 |
| Aug 1, 2025 | Mizuho | Anthony Petrone | Neutral | Maintains | $135.00 |
| Jul 16, 2025 | Mizuho | Anthony Petrone | Neutral | Maintains | $130.00 |
| Jul 15, 2025 | RBC Capital | Shagun Singh | Sector Perform | Maintains | $130.00 |
| May 5, 2025 | Morgan Stanley | Patrick Wood | Overweight | Maintains | $173.00 |
| May 5, 2025 | Truist Securities | Richard Newitter | Hold | Maintains | $137.00 |
| May 2, 2025 | RBC Capital | Shagun Singh | Sector Perform | Maintains | $145.00 |
| May 2, 2025 | Wells Fargo | Larry Biegelsen | Equal-Weight | Maintains | $137.00 |
| Apr 11, 2025 | Truist Securities | Richard Newitter | Hold | Maintains | $140.00 |
The following stocks are similar to Teleflex based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Teleflex Incorporated has a market capitalization of $4.79B with a P/E ratio of 82.6x. The company generates $1.99B in trailing twelve-month revenue with a -45.4% profit margin.
Revenue growth is -144.0% quarter-over-quarter, while maintaining an operating margin of +40.6% and return on equity of +1.6%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Develops and distributes single-use medical devices.
Teleflex generates revenue through the sale of its diverse range of single-use medical devices, focusing on critical care and surgical applications. The company serves various medical fields including vascular access, anesthesia, and emergency medicine, with a significant portion of sales coming from interventional cardiology and radiology products.
Headquartered in Wayne, Pennsylvania, Teleflex operates in over 40 countries with over 14,000 employees. The company is dedicated to improving patient health through innovative technologies and well-recognized brands, making it a crucial player in the global healthcare market.
Healthcare
Medical Instruments & Supplies
14,100
Mr. Stuart A. Randle
United States
1988
Teleflex has launched Demand and Supply Planning on the o9 AI platform to improve its integrated business planning and supply chain management capabilities.
Teleflex's adoption of o9's AI platform enhances its supply chain efficiency, potentially improving profitability and competitiveness, which can positively influence investor sentiment and stock performance.
Teleflex has divested key units, leading to uncertainty in earnings. It trades at 17-18x forward earnings, with potential normalized earnings of $8-9 per share and upside potential above $150.
Teleflex's divestitures create uncertainty in earnings, while current trading multiples suggest potential upside. Future guidance is clouded, impacting investor confidence and stock valuation.
Teleflex's Q4 earnings and revenues fell short of estimates due to shrinking margins, yet shares increased by 1.7% after hours following growth guidance for 2026 and a portfolio reshuffle.
Teleflex's earnings miss signals potential short-term challenges, but rising shares reflect confidence in future growth prospects and strategic changes, impacting investor sentiment and valuation.
Teleflex Incorporated (TFX) held its Q4 2025 earnings call, detailing financial performance and strategic updates. Further specifics on revenue and outlook were discussed during the call.
Teleflex's Q4 2025 earnings report will provide insights into financial performance, growth prospects, and market conditions, influencing stock valuation and investor sentiment.
Teleflex Incorporated (NYSE: TFX) reported 2025 revenue of $1,992.7 million, a 17.2% increase year-over-year, with adjusted revenue at $1,983.7 million, up 16.3%.
Teleflex's strong revenue growth and positive earnings per share indicate robust business performance, potentially boosting investor confidence and stock valuation.
Teleflex Incorporated (NYSE: TFX) declared a quarterly cash dividend of $0.34 per share, payable on March 31, 2026, to shareholders of record by March 6, 2026.
Teleflex's quarterly dividend announcement indicates financial stability and shareholder returns, potentially attracting income-focused investors and positively impacting stock performance.
Based on our analysis of 26 Wall Street analysts, Teleflex Incorporated (TFX) has a median price target of $135.00. The highest price target is $155.00 and the lowest is $115.00.
According to current analyst ratings, TFX has 2 Buy ratings, 9 Hold ratings, and 1 Sell ratings. The stock is currently trading at $107.32. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict TFX stock could reach $135.00 in the next 12 months. This represents a 25.8% increase from the current price of $107.32. Please note that this is a projection by Wall Street analysts and not a guarantee.
Teleflex generates revenue through the sale of its diverse range of single-use medical devices, focusing on critical care and surgical applications. The company serves various medical fields including vascular access, anesthesia, and emergency medicine, with a significant portion of sales coming from interventional cardiology and radiology products.
Price targets from Wall Street analysts for TFX are not currently available. The stock is trading at $107.32.
The lowest price target for TFX is $115.00 from at , which represents a 7.2% increase from the current price of $107.32.
The overall analyst consensus for TFX is neutral. Out of 26 Wall Street analysts, 2 rate it as Buy, 9 as Hold, and 1 as Sell, with a median price target of $135.00.
Stock price projections, including those for Teleflex Incorporated, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.